FDA-approved treatments delivered to your door. Save up to 90% with The HRT Club™.

Indicated for the treatment of moderate to severe vasomotor symptoms associated with the menopause, moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. Treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only).

Indicated for the treatment of moderate to severe VMS due to menopause and treatment of moderate to severe symptoms of VVA due to menopause.

Indicated to treat moderate to severe painful intercourse, a symptom of changes in and around your vagina, due to menopause.

Indicated for the treatment of moderate to severe menopausal VMS and VVA due to menopause.

Indicated for the treatment of vaginal atrophy due to low levels of estrogen.

Indicated for the treatment of Moderate to Severe Vasomotor Symptoms due to Menopause.

Indicated for the treatment of moderate to severe symptoms of VVA due to menopause.

Indicated for the treatment of moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis.

Indicated for the treatment of moderate to severe VMS due to menopause and treatment of moderate to severe symptoms of VVA due to menopause.

Indicated for the treatment of menstrual irregularities and for the protection of the endometrium (lining of the uterus).

Indicated for the treatment of moderate to severe menopausal VMS and VVA, and for the prevention of postmenopausal osteoporosis.

Indicated in a woman with a uterus for the treatment of moderate to severe vasomotor symptoms due to menopause.

Indicated for the treatment of moderate to severe VMS due to Menopause, moderate to severe VVA due to Menopause.

Testosterone gel is used to treat adult who have low or no testosterone due to certain medical conditions.

Used to treat adult males who have low or no testosterone due to certain medical conditions. Available by prescription with laboratory testing required.

Andrela™ is a compounded testosterone cypionate injection supplied as a ready-to-use, prefilled syringe for subcutaneous administration. It is prescribed by a licensed healthcare provider as part of an individualized hormone replacement therapy (HRT) treatment plan following a comprehensive clinical evaluation, including hormone level assessment.

Indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired) and Hypogonadotropic hypogonadism (congenital or acquired).

Indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired) and Hypogonadotropic hypogonadism (congenital or acquired).

Indicated to treat moderate to severe pain during sexual intercourse caused by changes in and around the vagina that happen with menopause.

Indicated for the treatment of erectile dysfunction (ED), and the signs and symptoms of benign prostatic hyperplasia (BPH).

Sildenafil tablet is a prescription medicine used to treat erectile dysfunction (ED). You will not get an erection just by taking this medicine. Sildenafil tablets help a man with erectile dysfunction get and keep an erection only when he is sexually excited (stimulated).

Indicated for use in women to stimulate the ovaries to produce multiple eggs as part of assisted reproductive technologies such as IVF. In men, it is indicated to treat infertility due to primary or secondary hypogonadotropic hypogonadism by stimulating sperm production.

Indicated for the treatment of adult males who have selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) and for the induction of ovulation and pregnancy in the anovulatory, for infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins.

Indicated for the treatment of ovulatory dysfunction in women desiring pregnancy.

Indicated for the prevention of pregnancy in women who elect to use oral combination contraceptives as a method of contraception. Indicated for the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who choose to use an oral contraceptive as their method of contraception.

Indicated for the prevention of pregnancy in women who elect to use oral combination contraceptives as a method of contraception.

Indicated for the prevention of pregnancy. It is a progestin-only oral contraceptive, sometimes called the "mini-pill".

Indicated for use by females of reproductive potential to prevent pregnancy.

Indicated for the prevention of pregnancy in women who elect to use oral combination contraceptives as a method of contraception.

Indicated for use by women of reproductive age to prevent pregnancy. Estarylla® is a norgestimate / ethinyl estradiol combination oral hormonal contraceptive (COC).

Indicated for use by females of reproductive potential to prevent pregnancy

Indicated for use by women of reproductive age to prevent pregnancy. EnilloRing is an estrogen/progestin combination hormonal contraceptive (CHC) vaginal ring.

Minoxidil 2.5 mg is indicated for the treatment of hypertension that is symptomatic or associated with target organ damage and not adequately controlled with maximum therapeutic doses of a diuretic plus two other antihypertensive agents.

Finasteride tablets are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY.

Indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Indicated for the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer.

Indicated to treat hormone receptor-positive breast cancer in postmenopausal women. This aromatase inhibitor works by lowering estrogen levels in the body, helping to slow or stop the growth of certain types of breast tumors.